Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2021
Q1
Sell
-1,000
Closed -$20.1K 1196
2020
Q4
$20.1K Hold
1,000
﹤0.01% 721
2020
Q3
$24.4K Hold
1,000
﹤0.01% 608
2020
Q2
$23.7K Hold
1,000
﹤0.01% 590
2020
Q1
$17.2K Hold
1,000
﹤0.01% 590
2019
Q4
$17.6K Hold
1,000
﹤0.01% 675
2019
Q3
$17.7K Hold
1,000
﹤0.01% 659
2019
Q2
$21.4K Hold
1,000
﹤0.01% 640
2019
Q1
$23.8K Hold
1,000
﹤0.01% 619
2018
Q4
$19.7K Hold
1,000
﹤0.01% 630
2018
Q3
$17.7K Hold
1,000
﹤0.01% 706
2018
Q2
$21.5K Hold
1,000
﹤0.01% 660
2018
Q1
$22.1K Sell
1,000
-104
-9% -$2.88K ﹤0.01% 654
2017
Q4
$33.6K Hold
1,104
﹤0.01% 560
2017
Q3
$26.8K Buy
+1,104
New +$29.4K ﹤0.01% 622

Other funds holding EXEL

RBC Europe's EXEL Position: Q1 2021 in Review

RBC Europe sold out of Exelixis (EXEL) in Q1 2021, closing a stake of 1,000 shares — an estimated $20.1K sold.

RBC Europe first reported a position in EXEL in Q3 2017 and held it in 14 quarters. The position peaked at $33.6K in Q4 2017. 347 funds tracked by Wall St. Rank hold EXEL as of Q1 2021.

  • RBC Europe reported no remaining Exelixis position as of Q1 2021 after selling out during the quarter.
  • RBC Europe sold 1,000 Exelixis shares in Q1 2021, an estimated $20.1K.
  • RBC Europe first reported a position in Exelixis in Q3 2017 and held it in 14 quarters.
  • RBC Europe's Exelixis position peaked at $33.6K in Q4 2017.
  • 347 funds tracked by Wall St. Rank held Exelixis as of Q1 2021.

Based on RBC Europe's 13F filing for Q1 2021, filed 9 Nov 2023.